UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

Clinical cancer research, 2012-11, Vol.18 (22), p.6373-6383

2012

Volltextzugriff (PDF)

Interleukin-6 and its receptor in cancer : Implications for translational therapeutics

Cancer, 2007-11, Vol.110 (9), p.1911-1928

2007

Volltextzugriff (PDF)

Inhibition of Src Expression and Activity Inhibits Tumor Progression and Metastasis of Human Pancreatic Adenocarcinoma Cells in an Orthotopic Nude Mouse Model

The American journal of pathology, 2006-03, Vol.168 (3), p.962-972

2006

Volltextzugriff (PDF)

PIK3CA Mutation H1047R Is Associated with Response to PI3K/AKT/mTOR Signaling Pathway Inhibitors in Early-Phase Clinical Trials

Cancer research (Chicago, Ill.), 2013-01, Vol.73 (1), p.276-284

2013

Volltextzugriff (PDF)

Insulin Growth Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor Temsirolimus in Patients with Refractory Ewing's Sarcoma Family Tumors

Clinical cancer research, 2012-05, Vol.18 (9), p.2625-2631

2012

Volltextzugriff (PDF)

A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas

Clinical cancer research, 2012-06, Vol.18 (12), p.3396-3406

2012

Volltextzugriff (PDF)

Accelerator-Based Stereotactic Radiosurgery for Brainstem Metastases

Neurosurgery, 2012-04, Vol.70 (4), p.953-958

2012

Volltextzugriff (PDF)

A Phase I Clinical Trial of Darinaparsin in Patients with Refractory Solid Tumors

Clinical cancer research, 2009-07, Vol.15 (14), p.4769-4776

2009

Volltextzugriff (PDF)

A Multicenter Phase I Trial of PX-866, an Oral Irreversible Phosphatidylinositol 3-Kinase Inhibitor, in Patients with Advanced Solid Tumors

Clinical cancer research, 2012-08, Vol.18 (15), p.4173-4182

2012

Volltextzugriff (PDF)

BRAF(V600) Inhibitor GSK2118436 Targeted Inhibition of Mutant BRAF in Cancer Patients Does Not Impair Overall Immune Competency

Clinical cancer research, 2012-04, Vol.18 (8), p.2326-2335

2012

Volltextzugriff (PDF)

Predictive Value of Phase I Trials for Safety in Later Trials and Final Approved Dose: Analysis of 61 Approved Cancer Drugs

Clinical cancer research, 2014-01, Vol.20 (2), p.281-288

2014

Volltextzugriff (PDF)

A Phase 1 Dose Escalation, Pharmacokinetic, and Pharmacodynamic Evaluation of eIF-4E Antisense Oligonucleotide LY2275796 in Patients with Advanced Cancer

Clinical cancer research, 2011-10, Vol.17 (20), p.6582-6591

2011

Volltextzugriff (PDF)

A First-in-Human Study of Conatumumab in Adult Patients with Advanced Solid Tumors

Clinical cancer research, 2010-12, Vol.16 (23), p.5883-5891

2010

Volltextzugriff (PDF)

Validation of the royal marsden hospital prognostic score in patients treated in the phase I clinical trials program at the MD Anderson Cancer Center

Cancer, 2012-03, Vol.118 (5), p.1422-1428

2012

Volltextzugriff (PDF)

Prevalence of Complementary Medicine Use in a Phase 1 Clinical Trials Program: The MD Anderson Cancer Center Experience

Cancer, 2011-11, Vol.117 (22), p.5142-5150

2011

Volltextzugriff (PDF)

A Phase I Trial of Liposomal Doxorubicin, Bevacizumab, and Temsirolimus in Patients with Advanced Gynecologic and Breast Malignancies

Clinical cancer research, 2011-11, Vol.17 (21), p.6840-6846

2011

Volltextzugriff (PDF)

Phase I study to determine the safety and pharmacokinetics of oral administration of TAS‐102 in patients with solid tumors

Cancer, 2006-09, Vol.107 (6), p.1383-1390

2006

Volltextzugriff (PDF)

West Nile Encephalitis in 2 Hematopoietic Stem Cell Transplant Recipients: Case Series and Literature Review

Clinical infectious diseases, 2003-10, Vol.37 (8), p.1044-1049

2003

Volltextzugriff (PDF)

Patients with Advanced Head and Neck Cancers Have Similar Progression-Free Survival on Phase I Trials and Their Last Food and Drug Administration-Approved Treatment

Clinical cancer research, 2010-08, Vol.16 (15), p.4031-4037

2010

Volltextzugriff (PDF)

Multiple squamous cell carcinomas of the skin after therapy with sorafenib combined with tipifarnib

Archives of dermatology (1960), 2008-06, Vol.144 (6), p.779

2008

Volltextzugriff (PDF)

Phase I Study of BIIB028, a Selective Heat Shock Protein 90 Inhibitor, in Patients with Refractory Metastatic or Locally Advanced Solid Tumors

Clinical cancer research, 2013-09, Vol.19 (17), p.4824-4831

2013

Volltextzugriff (PDF)

Inhibition of Histone Lysine Methylation Enhances Cancer-Testis Antigen Expression in Lung Cancer Cells: Implications for Adoptive Immunotherapy of Cancer

Cancer research (Chicago, Ill.), 2011-06, Vol.71 (12), p.4192-4204

2011

Volltextzugriff (PDF)

Tobacco Smoke Induces Polycomb-Mediated Repression of Dickkopf-1 in Lung Cancer Cells

Cancer research (Chicago, Ill.), 2009-04, Vol.69 (8), p.3570-3578

2009

Volltextzugriff (PDF)

Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy

Clinical cancer research, 2012-01, Vol.18 (1), p.77-90

2012

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Zeitschrift / SeriePlos One

KollektionSingle Journals

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(54)
Tagungsberichte
(1)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(55)
Humans
(52)
Life Sciences & Biomedicine
(50)
Science & Technology
(50)
Female
(35)
Male
(35)
Middle Aged
(32)
Aged
(29)
Tumors
(27)
Oncology
(26)
Adult
(23)
Pharmacology. Drug Treatments
(23)
Antineoplastic Agents
(22)
Neoplasms - Drug Therapy
(13)
Aged, 80 And Over
(11)
Pneumology
(11)
Antineoplastic Agents - Therapeutic Use
(10)
Treatment Outcome
(9)
Tumors Of The Respiratory System And Mediastinum
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

Interleukin-6 and its receptor in cancer : Implications for translational therapeutics

Inhibition of Src Expression and Activity Inhibits Tumor Progression and Metastasis of Human Pancreatic Adenocarcinoma Cells in an Orthotopic Nude Mouse Model

PIK3CA Mutation H1047R Is Associated with Response to PI3K/AKT/mTOR Signaling Pathway Inhibitors in Early-Phase Clinical Trials

Insulin Growth Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor Temsirolimus in Patients with Refractory Ewing's Sarcoma Family Tumors

A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas

Accelerator-Based Stereotactic Radiosurgery for Brainstem Metastases

A Phase I Clinical Trial of Darinaparsin in Patients with Refractory Solid Tumors

A Multicenter Phase I Trial of PX-866, an Oral Irreversible Phosphatidylinositol 3-Kinase Inhibitor, in Patients with Advanced Solid Tumors

BRAF(V600) Inhibitor GSK2118436 Targeted Inhibition of Mutant BRAF in Cancer Patients Does Not Impair Overall Immune Competency

Predictive Value of Phase I Trials for Safety in Later Trials and Final Approved Dose: Analysis of 61 Approved Cancer Drugs

A Phase 1 Dose Escalation, Pharmacokinetic, and Pharmacodynamic Evaluation of eIF-4E Antisense Oligonucleotide LY2275796 in Patients with Advanced Cancer

A First-in-Human Study of Conatumumab in Adult Patients with Advanced Solid Tumors

Validation of the royal marsden hospital prognostic score in patients treated in the phase I clinical trials program at the MD Anderson Cancer Center

Prevalence of Complementary Medicine Use in a Phase 1 Clinical Trials Program: The MD Anderson Cancer Center Experience

A Phase I Trial of Liposomal Doxorubicin, Bevacizumab, and Temsirolimus in Patients with Advanced Gynecologic and Breast Malignancies

Dual inhibition of the vascular endothelial growth factor pathway: A phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors

Phase I study to determine the safety and pharmacokinetics of oral administration of TAS‐102 in patients with solid tumors

West Nile Encephalitis in 2 Hematopoietic Stem Cell Transplant Recipients: Case Series and Literature Review

Patients with Advanced Head and Neck Cancers Have Similar Progression-Free Survival on Phase I Trials and Their Last Food and Drug Administration-Approved Treatment

Multiple squamous cell carcinomas of the skin after therapy with sorafenib combined with tipifarnib

Phase I Study of BIIB028, a Selective Heat Shock Protein 90 Inhibitor, in Patients with Refractory Metastatic or Locally Advanced Solid Tumors

Inhibition of Histone Lysine Methylation Enhances Cancer-Testis Antigen Expression in Lung Cancer Cells: Implications for Adoptive Immunotherapy of Cancer

Tobacco Smoke Induces Polycomb-Mediated Repression of Dickkopf-1 in Lung Cancer Cells

Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy

Aktive Filter

Suchergebnisse filtern